Losartan Potassium
- LOSARTAN POTASSIUM
- 124750-99-8
- ERYTHROPOIETIN
- Cozaar
- losartan potassium salt
- Create:2006-10-26
- Modify:2025-01-25
- 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
- Cozaar
- DuP 753
- DuP-753
- DuP753
- Losartan
- Losartan Monopotassium Salt
- Losartan Potassium
- MK 954
- MK-954
- MK954
- Monopotassium Salt, Losartan
- Potassium, Losartan
- Salt, Losartan Monopotassium
- LOSARTAN POTASSIUM
- 124750-99-8
- ERYTHROPOIETIN
- Cozaar
- losartan potassium salt
- Losacar
- Losaprex
- Lorzaar
- Losata
- Tancin
- Nu-Lotan
- Hyzaar
- Losartan monopotassium salt
- Aradois
- Lifezar
- Lortaan
- Lorzaan
- Losacor
- Tenopres
- Ocsaar
- Lotim
- Niten
- Zaart
- Neo Lotan
- Presartan-50
- MK-0954
- MK 954
- MK0954
- DuP 753
- DuP-753
- Du Pont 753
- L-158086
- DuP753
- DU PONT-753
- UNII-3ST302B24A
- 3ST302B24A
- E-3340
- MK 0954
- Losartan Potassium (DuP 753)
- Losartan potassium [USAN:USP]
- DTXSID3044209
- 2-Butyl-4-chloro-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)imidazole-5-methanol, monopotassium salt
- HYZAAR COMPONENT LOSARTAN POTASSIUM
- MK-954
- 2-Butyl-4-chloro-1-(2'-(tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-imidazole-5-methanol potassium
- 124750-99-8 (Ka+)
- 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, monopotassium salt
- Losartan potassium (USAN:USP)
- LOSARTAN POTASSIUM (MART.)
- LOSARTAN POTASSIUM [MART.]
- LOSARTAN POTASSIUM (USP-RS)
- LOSARTAN POTASSIUM [USP-RS]
- losartanpotassium
- LOSARTAN POTASSIUM (EP MONOGRAPH)
- LOSARTAN POTASSIUM [EP MONOGRAPH]
- 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, monopotassium salt
- LOSARTAN POTASSIUM (USP MONOGRAPH)
- LOSARTAN POTASSIUM [USP MONOGRAPH]
- Potassium, Losartan
- Losartan potassium [USAN]
- Monopotassium Salt, Losartan
- Salt, Losartan Monopotassium
- Covance
- Losatan Potassium
- Losortan Potassium
- Losartan Potatssium
- 2-Butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol, Monopotassium Salt
- Losartan potassium; Potassium 5-[4'-[[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]biphenyl-2-yl]tetrazol-1-ide
- potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)biphenyl-2-yl)tetrazol-1-ide
- Losartan Potassium?
- Cozaar (TN)
- Losartan potassium,(S)
- losartan potassium tablet
- CHEMBL995
- SCHEMBL42079
- EPO
- MLS001401407
- potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
- Ex-89
- LOSARTAN POTASSIUM25 mg
- LOSARTAN POTASSIUM50 mg
- DTXCID1024209
- LOSARTAN POTASSIUM [JAN]
- LOSARTAN POTASSIUM100 mg
- Losartan potassium (JP17/USP)
- LOSARTAN POTASSIUM [HSDB]
- HMS2051M12
- HMS2090O22
- HMS2235F20
- HMS3369F08
- HMS3393M12
- LOSARTAN POTASSIUM [VANDF]
- BCP05332
- BCP29397
- LOSARTAN POTASSIUM [WHO-DD]
- Losartan Potassium Tablets, 25 mg
- Losartan Potassium Tablets, 50 mg
- Losartan Potassium Tablets, 100 mg
- AKOS015955543
- AKOS025310168
- AC-1072
- CCG-100869
- Losartan potassium, analytical standard
- NC00119
- LOSARTAN MONOPOTASSIUM SALT [MI]
- LOSARTAN POTASSIUM [ORANGE BOOK]
- 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]imidazole-5-methanol Potassium Salt
- BL164642
- SMR000469593
- L0232
- LOSARTAN POTASSIUM COMPONENT OF HYZAAR
- NS00076270
- D00357
- AB01275507-01
- SR-05000001514
- SR-05000001514-1
- Q27257991
- Losartan potassium, European Pharmacopoeia (EP) Reference Standard
- Losartan Potassium is known as a potent, synthetic AT1 receptor antagonist.
- Losartan potassium, United States Pharmacopeia (USP) Reference Standard
- Losartan Potassium, Pharmaceutical Secondary Standard; Certified Reference Material
- Monopotassium 5-((4'-(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl)biphenyl-2-yl)-1H-tetrazol-1-ide
- Losartan (has active moiety)
- Hydrochlorothiazide; Losartan Potassium (component of)
- Epoetin Alfa (annotation moved to)
H302 (75.7%): Harmful if swallowed [Warning Acute toxicity, oral]
H317 (71.7%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H318 (69.4%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
H319 (14.5%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H360 (72.3%): May damage fertility or the unborn child [Danger Reproductive toxicity]
H361 (15.6%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
H362 (68.2%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]
H373 (62.4%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]
P203, P260, P261, P263, P264, P264+P265, P270, P272, P280, P301+P317, P302+P352, P305+P351+P338, P305+P354+P338, P317, P318, P319, P321, P330, P333+P317, P337+P317, P362+P364, P405, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 173 reports by companies from 25 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 4 (75.7%)
Skin Sens. 1 (71.7%)
Eye Dam. 1 (69.4%)
Eye Irrit. 2 (14.5%)
Repr. 1B (72.3%)
Repr. 2 (15.6%)
Lact. (68.2%)
STOT RE 2 (62.4%)
M Chen, V Vijay, Q Shi, Z Liu, H Fang, W Tong. FDA-Approved Drug Labeling for the Study of Drug-Induced Liver Injury, Drug Discovery Today, 16(15-16):697-703, 2011. PMID:21624500 DOI:10.1016/j.drudis.2011.05.007
M Chen, A Suzuki, S Thakkar, K Yu, C Hu, W Tong. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 2016, 21(4): 648-653. PMID:26948801 DOI:10.1016/j.drudis.2016.02.015
◉ Summary of Use during Lactation
Because no information is available on the use of losartan during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
◉ Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
◉ Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=OXCMYAYHXIHQOA-UHFFFAOYSA-N
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jspErythropoietinhttps://ctdbase.org/detail.go?type=chem&acc=D004921
- Drug Gene Interaction database (DGIdb)LICENSEThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.http://www.dgidb.org/downloadsLOSARTAN POTASSIUMhttps://www.dgidb.org/drugs/rxcui:203160
- Therapeutic Target Database (TTD)Erythropoietinhttps://idrblab.net/ttd/data/drug/details/D0G5JW
- ChemIDplusLosartan potassium [USAN:USP]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0124750998ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- EPA DSSToxLosartan potassiumhttps://comptox.epa.gov/dashboard/DTXSID3044209CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-notice(1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol, potassium salthttps://echa.europa.eu/substance-information/-/substanceinfo/100.155.381Losartan potassiumhttps://echa.europa.eu/substance-information/-/substanceinfo/100.184.839(1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol, potassium salt (EC: 627-032-3)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/159997Losartan potassium (EC: 658-044-7)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/189761
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingLOSARTAN POTASSIUMhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/3ST302B24A
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licenceLOSARTAN POTASSIUMhttps://platform.opentargets.org/drug/CHEMBL995
- DailyMed
- Drug Induced Liver Injury Rank (DILIrank) DatasetLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- Drugs and Lactation Database (LactMed)
- Drugs@FDALICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingLOSARTAN POTASSIUMhttps://www.accessdata.fda.gov/scripts/cder/daf/
- European Medicines Agency (EMA)LICENSEInformation on the European Medicines Agency's (EMA) website is subject to a disclaimer and copyright and limited reproduction notices.https://www.ema.europa.eu/en/about-us/legal-noticeLosartan potassium (P/9/2008)https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000008-pip01-07
- EU Clinical Trials Register
- FDA Orange BookLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlTherapeutic category of drugs in Japanhttp://www.genome.jp/kegg-bin/get_htext?br08301.kegUSP drug classificationhttp://www.genome.jp/kegg-bin/get_htext?br08302.kegAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.kegTarget-based classification of drugshttp://www.genome.jp/kegg-bin/get_htext?br08310.kegDrugs listed in the Japanese Pharmacopoeiahttp://www.genome.jp/kegg-bin/get_htext?br08311.keg
- National Drug Code (NDC) DirectoryLICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- NIPH Clinical Trials Search of Japan
- NLM RxNorm TerminologyLICENSEThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.htmllosartan potassiumhttps://rxnav.nlm.nih.gov/id/rxnorm/203160
- SpectraBaseLosartan potassiumhttps://spectrabase.com/spectrum/bUbNcf9EoNLosartan potassiumhttps://spectrabase.com/spectrum/LeA4w4QCJhlLosartan potassiumhttps://spectrabase.com/spectrum/KvGCOyVtYwF
- Springer Nature
- Thieme ChemistryLICENSEThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc-nd/4.0/
- Wikidatalosartan potassiumhttps://www.wikidata.org/wiki/Q27257991
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlAngiotensin II Type 1 Receptor Blockershttps://www.ncbi.nlm.nih.gov/mesh/68047228Anti-Arrhythmia Agentshttps://www.ncbi.nlm.nih.gov/mesh/68000889Antihypertensive Agentshttps://www.ncbi.nlm.nih.gov/mesh/68000959
- PubChem
- WHO Anatomical Therapeutic Chemical (ATC) ClassificationLICENSEUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.https://www.whocc.no/copyright_disclaimer/
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/NORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 389317755https://pubchem.ncbi.nlm.nih.gov/substance/389317755